Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders
Completed
Johns Hopkins University
Phase 2
1985-01-01
OBJECTIVES:
I. Assess the safety and efficacy of sodium phenylbutyrate, sodium benzoate, sodium
phenylacetate, and dietary intervention in patients with urea cycle disorders.
Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders
Completed
National Center for Research Resources (NCRR)
Phase 2
1985-01-01
OBJECTIVES:
I. Assess the safety and efficacy of sodium phenylbutyrate, sodium benzoate, sodium
phenylacetate, and dietary intervention in patients with urea cycle disorders.
Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
Terminated
Horizon Pharma Ireland, Ltd., Dublin Ireland
Phase 2
2007-12-01
The primary purpose of this study is to evaluate the safety and effectiveness of Ammonul® in
subjects who become hospitalized with Grade 3 or 4 hepatic encephalopathy (HE).
To determine the safety and tolerability of single oral doses of HPN-100 as a formulation
(GT4P-F) and GT4P as the active pharmaceutical ingredient (GT4P-API) administered to healthy
male subjects.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
